MacroGenics
MGNX
113 hedge funds and large institutions have $626M invested in MacroGenics in 2015 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 47 increasing their positions, 29 reducing their positions, and 15 closing their positions.
62% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 29
40% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 15
6% more funds holding
Funds holding: 107 → 113 (+6)
5% more capital invested
Capital invested by funds: $595M → $626M (+$31.2M)
62% less call options, than puts
Call options by funds: $120K | Put options by funds: $317K
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$27.5M |
| 2 |
State Street
Boston,
Massachusetts
|
+$22.3M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$17.1M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$7.95M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$7.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$15.9M |
| 2 |
PC
PointState Capital
New York
|
-$13.2M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
-$5.7M |
| 4 |
Morgan Stanley
New York
|
-$3.85M |
| 5 |
PA
Perceptive Advisors
New York
|
-$3.72M |
MGNX Hedge Fund Activity: Q1 2015 in Review
113 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q1 2015, worth a combined $626M — up 5.2% from $595M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new MGNX positions and 15 closed out — a net gain of 6 holders — while 47 added to existing stakes and 29 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $27.5M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $15.9M sold.
- 113 institutional investors held MacroGenics (MGNX) as of Q1 2015, up from 107 in Q4 2014.
- Funds reported $626M of MacroGenics stock for Q1 2015, up 5.2% quarter-over-quarter.
- 21 funds opened new MacroGenics positions in Q1 2015 and 15 closed out, a net change of +6 holders.
- The largest MacroGenics buyer in Q1 2015 was Point72 Asset Management, an estimated $27.5M added.
- The largest MacroGenics seller in Q1 2015 was EcoR1 Capital, an estimated $15.9M sold.
Based on aggregated 13F filings for Q1 2015.